Trial Details

WITHDRAWN
Basic Information
Clinical ID c1184
Identifier NCT05453916
Trial Title Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome With Diarrhea
Interventions DRUG: Nitazoxanide 500Mg Oral Tablet|DRUG: Rifaximin 550Mg Tab
Participant Information
Sponsor Sadat City University
City Menoufia
Country/Region Egypt
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1|PHASE2
Time Information
Start Date 2022-07-01
Primary Completion Date 2024-07-01
Completion Date 2024-12-31